Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components
RHEINBREITBACH, Germany, August 29, 2011 /PRNewswire/ –
Jennewein Biotechnologie today announced that the company has signed a
license agreement with Pfizer Nutrition to develop and market two Human Milk
Human Milk Oligosaccharides represent a major component of mother’s
milk, and provide short and long-term benefits to infants from birth
onwards. Scientific research has shown that HMOs can significantly lower
infants’ risk of infection during the time of lactation. In addition, these
compounds are known to influence colonization of beneficial bacteria and
support healthy immune development.
The partnership will focus on enabling the functional and immunological
benefits of HMOs to become available to infants being fed with infant
formulas. Human milk, the “gold standard” due to its special composition of
lipids, proteins and HMOs, is the best nutrition for infants.
“Building upon nearly a century as pioneers in infant nutritional
science, we are constantly striving to more closely replicate the
composition and functional benefits of breast milk, and this partnership
truly helps further this mission,” stated John Troup, PhD, Vice President,
Global Research & Development, Pfizer Nutrition.
Dr. Stefan Jennewein, Managing Director and Cofounder of Jennewein
Biotechnologie, underlines, “Complex oligosaccharides in general and HMOs in
particular show an enormous potential for use in human nutrition. The
cooperation between Pfizer Nutrition and Jennewein Biotechnologie will
accelerate the developments in this field by bringing together specific
Jennewein plans to also focus on adult nutrition, in addition to infant
formulas, in the commercialization of HMOs so as to bring the benefits of
this natural product to a broader group of consumers.
About Jennewein Biotechnologie
Jennewein Biotechnologie GmbH, found in 2005 in Rheinbreitbach
(Germany), is a science based company in the field of industrial
biotechnology. The company is focusing its activities on the development of
innovative production processes for scarce and complex mono- and
oligosaccharides. The mission of Jennewein Biotechnologie is to provide
sugars with scientifically proven health benefits and to make these
available to larger consumer groups.
About Pfizer Nutrition
Pfizer Nutrition, formerly Wyeth Nutrition, is part of Pfizer Inc.
Pfizer Nutrition supports the company’s mission to improve health and
well-being at every stage of life, bringing breadth and depth of consumer
and scientific insight to new populations and new markets around the world.
Pfizer Nutrition brings together almost a century of experience in which the
company has leveraged clinical rigor, scientific research, world class
manufacturing and product safety standards to drive scientifically-sound
solutions that offer parents confidence, help nourish children and support
their healthy futures. We develop premium-quality nutritional products that
are scientifically-designed to meet the needs of infants and young children,
as well as pregnant and lactating mothers.
For Immediate Release Media Inquiries: Jennewein Biotechnologie GmbH Amelie Jennewein Maarweg 32 53619 Rheinbreitbach Germany Tel. +49(0)2224-967-9669 Fax. +49(0)2224-988-0854 Email: email@example.com
SOURCE Jennewein Biotechnologie GmbH